2/19/2008

The FDA has granted approval for Siemens AG's health care unit to market its Versant 440 laboratory system, designed to detect hepatitis C virus in patients' blood. The company said the device has been cleared in Europe, Africa and parts of Asia.

Full Story:
CNNMoney

Related Summaries